FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2161054103> ?p ?o ?g. }

• W2161054103 endingPage "1207" @default.
• W2161054103 startingPage "1204" @default.
• W2161054103 abstract "<b>Objective:</b> To evaluate the efficacy and side effects of oral pilocarpine for the treatment of ocular symptoms in patients with primary Sjögren’s syndrome (SS). <b>Methods:</b> A 12 week, single centre, randomised controlled study was performed. Twenty nine patients were randomly assigned to receive oral pilocarpine (5 mg twice a day), 28 only artificial tears, and 28 inferior puncta occlusion. Patients receiving oral pilocarpine and those with inferior puncta occlusion also received artificial tears. Patients were evaluated at baseline and throughout the study for their subjective global assessment of dry eyes and for their objective assessment of dry eyes (Schirmer’s-I test, rose bengal test, and imprint test). <b>Results:</b> Patients taking oral pilocarpine had significant improvement in subjective global assessment of dry eyes, as was evaluated by improvement of >55 mm on a visual analogue scale (VAS) for responses to the eye questionnaire, compared with patients treated with artificial tears (p<0.001) and those with inferior puncta occlusion (p<0.05). Furthermore, patients receiving oral pilocarpine also showed greater objective improvement, as measured by the rose bengal test (p<0.05), while Schirmer’s-I test showed no differences between the treated groups. Commonly reported adverse events were headache, increased sweating, nausea, and vomiting in the pilocarpine group, while one patient in the inferior puncta occlusion group had blepharitis and was withdrawn from the study. <b>Conclusion:</b> 10 mg of pilocarpine daily given to patients with SS for 12 weeks had a beneficial effect on subjective eye symptoms, as evaluated by improvement >55 mm on a VAS. Additionally, an improvement of rose bengal staining was noted, but an increase in tear production, as measured by the Schirmer-I test, was not substantiated." @default.
• W2161054103 created "2016-06-24" @default.
• W2161054103 creator A5005678543 @default.
• W2161054103 creator A5021544014 @default.
• W2161054103 creator A5025992165 @default.
• W2161054103 creator A5037489257 @default.
• W2161054103 creator A5045724289 @default.
• W2161054103 creator A5053973975 @default.
• W2161054103 creator A5063621110 @default.
• W2161054103 creator A5064363682 @default.
• W2161054103 date "2003-12-01" @default.
• W2161054103 modified "2023-10-06" @default.
• W2161054103 title "Oral pilocarpine for the treatment of ocular symptoms in patients with Sjogren's syndrome: a randomised 12 week controlled study" @default.
• W2161054103 cites W1825541386 @default.
• W2161054103 cites W1985992810 @default.
• W2161054103 cites W1992063412 @default.
• W2161054103 cites W1992757254 @default.
• W2161054103 cites W1998872011 @default.
• W2161054103 cites W2004151862 @default.
• W2161054103 cites W2013068641 @default.
• W2161054103 cites W2016139727 @default.
• W2161054103 cites W2032387707 @default.
• W2161054103 cites W2039924752 @default.
• W2161054103 cites W2056145311 @default.
• W2161054103 cites W2064439068 @default.
• W2161054103 cites W2072785268 @default.
• W2161054103 cites W2084043206 @default.
• W2161054103 cites W2147253907 @default.
• W2161054103 cites W2147816599 @default.
• W2161054103 cites W2167385753 @default.
• W2161054103 cites W2175593968 @default.
• W2161054103 cites W2214327097 @default.
• W2161054103 cites W2416207827 @default.
• W2161054103 cites W2594653134 @default.
• W2161054103 cites W303895199 @default.
• W2161054103 doi "https://doi.org/10.1136/ard.2002.003889" @default.
• W2161054103 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1754388" @default.
• W2161054103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14644860" @default.
• W2161054103 hasPublicationYear "2003" @default.
• W2161054103 type Work @default.
• W2161054103 sameAs 2161054103 @default.
• W2161054103 citedByCount "119" @default.
• W2161054103 countsByYear W21610541032012 @default.
• W2161054103 countsByYear W21610541032013 @default.
• W2161054103 countsByYear W21610541032014 @default.
• W2161054103 countsByYear W21610541032015 @default.
• W2161054103 countsByYear W21610541032016 @default.
• W2161054103 countsByYear W21610541032017 @default.
• W2161054103 countsByYear W21610541032018 @default.
• W2161054103 countsByYear W21610541032019 @default.
• W2161054103 countsByYear W21610541032020 @default.
• W2161054103 countsByYear W21610541032021 @default.
• W2161054103 countsByYear W21610541032022 @default.
• W2161054103 countsByYear W21610541032023 @default.
• W2161054103 crossrefType "journal-article" @default.
• W2161054103 hasAuthorship W2161054103A5005678543 @default.
• W2161054103 hasAuthorship W2161054103A5021544014 @default.
• W2161054103 hasAuthorship W2161054103A5025992165 @default.
• W2161054103 hasAuthorship W2161054103A5037489257 @default.
• W2161054103 hasAuthorship W2161054103A5045724289 @default.
• W2161054103 hasAuthorship W2161054103A5053973975 @default.
• W2161054103 hasAuthorship W2161054103A5063621110 @default.
• W2161054103 hasAuthorship W2161054103A5064363682 @default.
• W2161054103 hasBestOaLocation W21610541031 @default.
• W2161054103 hasConcept C118487528 @default.
• W2161054103 hasConcept C118552586 @default.
• W2161054103 hasConcept C126322002 @default.
• W2161054103 hasConcept C141071460 @default.
• W2161054103 hasConcept C14184104 @default.
• W2161054103 hasConcept C197934379 @default.
• W2161054103 hasConcept C2776076399 @default.
• W2161054103 hasConcept C2776268601 @default.
• W2161054103 hasConcept C2776883082 @default.
• W2161054103 hasConcept C2777204577 @default.
• W2161054103 hasConcept C2778186239 @default.
• W2161054103 hasConcept C2778275304 @default.
• W2161054103 hasConcept C2778837293 @default.
• W2161054103 hasConcept C2780580376 @default.
• W2161054103 hasConcept C2780852908 @default.
• W2161054103 hasConcept C42219234 @default.
• W2161054103 hasConcept C504460877 @default.
• W2161054103 hasConcept C71924100 @default.
• W2161054103 hasConceptScore W2161054103C118487528 @default.
• W2161054103 hasConceptScore W2161054103C118552586 @default.
• W2161054103 hasConceptScore W2161054103C126322002 @default.
• W2161054103 hasConceptScore W2161054103C141071460 @default.
• W2161054103 hasConceptScore W2161054103C14184104 @default.
• W2161054103 hasConceptScore W2161054103C197934379 @default.
• W2161054103 hasConceptScore W2161054103C2776076399 @default.
• W2161054103 hasConceptScore W2161054103C2776268601 @default.
• W2161054103 hasConceptScore W2161054103C2776883082 @default.
• W2161054103 hasConceptScore W2161054103C2777204577 @default.
• W2161054103 hasConceptScore W2161054103C2778186239 @default.
• W2161054103 hasConceptScore W2161054103C2778275304 @default.
• W2161054103 hasConceptScore W2161054103C2778837293 @default.
• W2161054103 hasConceptScore W2161054103C2780580376 @default.
• W2161054103 hasConceptScore W2161054103C2780852908 @default.
• W2161054103 hasConceptScore W2161054103C42219234 @default.

• next